Literature DB >> 34677657

Impact of nocturnal hypoxemia on the recurrence of atrial tachyarrhythmia after catheter ablation of atrial fibrillation.

Keisuke Suzuki1,2, Koji Miyamoto1, Akinori Wakamiya1, Nobuhiko Ueda1, Kenzaburo Nakajima1, Tsukasa Kamakura1, Mitsuru Wada1, Kenichiro Yamagata1, Kohei Ishibashi1, Yuko Inoue1, Takashi Noda1, Satoshi Nagase1, Takeshi Aiba1, Tomoyuki Yambe2, Kengo Kusano3.   

Abstract

Factors causing atrial tachyarrhythmia recurrence after catheter ablation (CA) of atrial fibrillation (AF) remain undetermined. This study aimed to investigate the effect of nocturnal hypoxemia on the recurrence of atrial tachyarrhythmia after CA of AF. Among 594 patients with AF who underwent an ambulatory sleep study at the National Cerebral and Cardiovascular Center, Suita, Osaka, Japan (2014-2019), 365 underwent CA of AF; 290 patients who underwent CA were followed up for > 3 months. Multivariate Cox regression analysis was used to calculate hazard ratios (HRs) using clinical variables, to identify the independent predictors of atrial tachyarrhythmia recurrence after the final CA. Atrial tachyarrhythmia recurred in 45 of 290 (15.5%) patients during the median follow-up period of 479 days (interquartile range 225-1002). On the performing multivariate analysis of the data of patients who did not receive continuous positive airway pressure (CPAP), severe nocturnal hypoxemia [defined as the percentage of sleep time spent with SaO2 of < 90% (T90) over 20%] [HR 8.53, 95% confidence interval (CI) 1.872-38.814; P < 0.01] and an 1 mL/m2 increase in the left atrial volume index (HR 1.02, 95% CI 1.004-1.044; P = 0.02) were found to be independently associated with the recurrence of atrial tachyarrhythmia. In addition, the rates of freedom from atrial tachyarrhythmia after the final AF ablation with CPAP were significantly lower in the group with more severe nocturnal hypoxemia (Log-rank P = 0.03). In conclusion, it is necessary to consider both, AHI and nocturnal hypoxia while performing an ambulatory sleep apnea study. CA may be less effective in patients with more severe nocturnal hypoxia, despite the administration of CPAP.
© 2021. Springer Japan KK, part of Springer Nature.

Entities:  

Keywords:  Atrial fibrillation; Catheter ablation; Nocturnal hypoxemia; Obstructive sleep apnea; Peripheral arterial tonometer

Mesh:

Year:  2021        PMID: 34677657     DOI: 10.1007/s00380-021-01969-x

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  3 in total

1.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.

Authors:  Carlos A Morillo; Atul Verma; Stuart J Connolly; Karl H Kuck; Girish M Nair; Jean Champagne; Laurence D Sterns; Heather Beresh; Jeffrey S Healey; Andrea Natale
Journal:  JAMA       Date:  2014-02-19       Impact factor: 56.272

2.  Different Implications of Heart Failure, Ischemic Stroke, and Mortality Between Nonvalvular Atrial Fibrillation and Atrial Flutter-a View From a National Cohort Study.

Authors:  Yu-Sheng Lin; Tien-Hsing Chen; Ching-Chi Chi; Ming-Shyan Lin; Tao-Hsin Tung; Chi-Hung Liu; Yung-Lung Chen; Mien-Cheng Chen
Journal:  J Am Heart Assoc       Date:  2017-07-21       Impact factor: 5.501

3.  Quick Diagnosis in Obstructive Sleep Apnea Syndrome: WatchPAT-200.

Authors:  Tijen Ceylan; Hikmet Fırat; Gökhan Kuran; Sadık Ardıç; Esra Bilgin; Fatih Celenk
Journal:  Iran Red Crescent Med J       Date:  2012-08-30       Impact factor: 0.611

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.